Document is current
Any future updates will be listed below
-
Authors
Driessen, Stan https://orcid.org/0000-0003-1485-9732
Lazarus, Jeffrey V. https://orcid.org/0000-0001-9618-2299
Drenth, Joost P. H.
Tushuizen, Maarten E.
Holleboom, Adriaan G.
- License Information
-
More Information
Article History
First Online: 17 February 2026
Competing interests
: J.V.L. acknowledges grants to ISGlobal from AbbVie, Boehringer Ingelheim, Echosens, Gilead Sciences, Madrigal Pharmaceuticals, Moderna, MSD, Novo Nordisk, Pfizer, and Roche Diagnostics, consulting fees from Echosens, GSK, Novavax, Novo Nordisk, Pfizer, and Prosciento, and payment or honoraria for lectures from AbbVie, Echosens, Gilead Sciences, Janssen, Moderna, MSD, Novo Nordisk, and Pfizer, outside of this work. J.P.H.D. acknowledges consulting fees from CAMURUS; all proceeds go directly to the Amsterdam UMC. A.G.H. received consultant fees from Echosens, Inventiva, Lilly, MSD and NovoNordisk. The other authors declare no competing interests.
